ライフサイエンスコーパス: pseudophakic

1 158 of 2620 eyes (44%) with primary RRD were pseudophakic.

2 rates when operated eyes were phakic versus pseudophakic.

3 ant glaucoma, 5 eyes were phakic and 23 were pseudophakic.

4 DMEK-only patients were pseudophakic.

5 male; mean [SD] age, 5.65 [3.32] years) were pseudophakic.

6 Two-thirds (153 of 230) were pseudophakic.

7 lines of VA loss: 4 were phakic, and 2 were pseudophakic.

8 65.2%) were phakic, and 15 of 15 (100%) were pseudophakic.

9 78.9%) were phakic and 22 of 24 (91.7%) were pseudophakic.

10 ry 2 months [range 1-13 months]) and 16 were pseudophakic (29 months [range 2-92 months]).

11 Visual axis opacification was more common in pseudophakic (32%) than aphakic (8%) eyes (P = 0.009).

12 Most fellow eyes were pseudophakic (72.1%).

13 al (84.1% vs 74.4%; P = 0.16), phakic versus pseudophakic (79.1% vs 78.0%; P = 0.88), and macula-on v

14 ntraretinal fluid in the centre subfield, be pseudophakic (after cataract removal), and have a best-c

15 Of 4,231 eyes, 1,212 were pseudophakic and 3,019 phakic, among which 310 had catar

16 of follow-up, the mean axial lengths of the pseudophakic and aphakic eyes were 2.0 +/- 0.2 mm and 2.

17 P acuity revealed amblyopic deficits in both pseudophakic and aphakic eyes.

18 After excluding pseudophakic and aphakic individuals, the study included

19 However, in pseudophakic and aphakic patients, PPV seems to be less

20 k) lenses implanted in eyes that are already pseudophakic and considerations on IOLs used in the pedi

21 All patients were pseudophakic and had a glaucoma drainage device in place

22 ting features differed significantly between pseudophakic and phakic RD, with greater occurrence of i

23 A total of 34 eyes (29 patients) were pseudophakic and underwent only DMEK (DMEK-only), and 80

24 In pseudophakic and uveitic macular edema, steroid implants

25 Combining phakic, pseudophakic, and aphakic groups, those treated with scl

26 All four of the eyes were pseudophakic, and they had undergone prior vitrectomies.

27 Report of three patients with pseudophakic angle-closure from a Soemmering ring.

28 ee mechanisms of the Soemmering ring induced pseudophakic angle-closure in three patients were demons

29 Schematic eyes with different values of pseudophakic anterior chamber depth (ACD), refractive cy

30 nd postoperative BCVA at 6 months or more in pseudophakic/aphakic eyes.

31 ; P = 0.03) between the PPV and SB groups in pseudophakic/aphakic eyes.

32 In the pseudophakic/aphakic group, there were no significant di

33 Analysis was divided into phakic and pseudophakic/aphakic patients.

34 elial keratoplasty procedures, 576 eyes were pseudophakic at the end of surgery.

35 Two of the 165 DMEK cases were performed for pseudophakic bullous keratopathy (2 cases, 1 in each coh

36 Fuchs endothelial corneal dystrophy (32.5%), pseudophakic bullous keratopathy (35%), previous failed

37 ndothelium compared with normal controls and pseudophakic bullous keratopathy (iatrogenic CE cell los

38 re (n = 8), DSAEK graft failure (n = 3), and pseudophakic bullous keratopathy (n = 2).

39 ation for surgery (n = 127; 90%) followed by pseudophakic bullous keratopathy (n = 4; 4%) and regraft

40 visual outcomes than penetrating grafts for pseudophakic bullous keratopathy (P <0.001).

41 ent DSAEK for Fuchs endothelial dystrophy or pseudophakic bullous keratopathy (PBK) at a single insti

42 FED and pseudophakic bullous keratopathy (PBK) corneal buttons w

43 from age-matched normal autopsy corneas and pseudophakic bullous keratopathy (PBK) corneas.

44 Fuchs endothelial dystrophy and 9 eyes with pseudophakic bullous keratopathy (PBK) that underwent DS

45 nus (KC), Fuchs endothelial dystrophy (FED), pseudophakic bullous keratopathy (PBK), infection and ot

46 ents with Fuchs endothelial dystrophy (FED), pseudophakic bullous keratopathy (PBK), or keratoconus w

47 s correlation was strongest in patients with pseudophakic bullous keratopathy (r = -0.62 [P = .01]).

48 tudies were performed on eight cases each of pseudophakic bullous keratopathy and healthy corneas.

49 ed PK, whose primary surgical indication was pseudophakic bullous keratopathy at a single tertiary ce

50 nt DSAEK with Fuchs endothelial dystrophy or pseudophakic bullous keratopathy at a single tertiary ce

51 Oxidative DNA damage was not detected in pseudophakic bullous keratopathy corneas, whereas it col

52 n = 2074) for Fuchs endothelial dystrophy or pseudophakic bullous keratopathy from January 2006 throu

53 surgery for Fuchs' endothelial dystrophy and pseudophakic bullous keratopathy in patients without oth

54 DMEK surgery in the treatment of pseudophakic bullous keratopathy in the presence of sf-I

55 Pseudophakic bullous keratopathy manifests an abnormal c

56 atients with Fuchs endothelial dystrophy and pseudophakic bullous keratopathy undergoing DSAEK surger

57 EK failure in pseudophakic bullous keratopathy was associated with cen

58 toplasties performed for Fuchs' dystrophy or pseudophakic bullous keratopathy was poorer than surviva

59 unction from Fuchs' endothelial dystrophy or pseudophakic bullous keratopathy were randomized to DMEK

60 othelium from Fuchs endothelial dystrophy or pseudophakic bullous keratopathy who were considered goo

61 othelium from Fuchs endothelial dystrophy or pseudophakic bullous keratopathy who were good candidate

62 ndicated with Fuchs endothelial dystrophy or pseudophakic bullous keratopathy with or without catarac

63 Indications for DMEK included 7 cases of pseudophakic bullous keratopathy, 2 cases of failed DMEK

64 For both Fuchs endothelial dystrophy and pseudophakic bullous keratopathy, EK achieved better ave

65 For optical grafts, pseudophakic bullous keratopathy, postinfectious corneal

66 In eyes with pseudophakic bullous keratopathy, the EndoGlide group ha

67 complications associated with them, such as pseudophakic bullous keratopathy, uveitis-glaucoma-hyphe

68 sulted in better graft survival in eyes with pseudophakic bullous keratopathy.

69 are being performed for Fuchs' dystrophy and pseudophakic bullous keratopathy.

70 rder to treat secondary corneal edema due to pseudophakic bullous keratopathy.

71 s relationship is strongest in patients with pseudophakic bullous keratopathy.

72 ing DSAEK for Fuchs endothelial dystrophy or pseudophakic bullous keratopathy.

73 ear-old man underwent DSAEK procedure due to pseudophakic bullous keratopathy.

74 ice), progressive endothelial cell loss, and pseudophakic bullous keratopathy.

75 the Middle East, Africa, and South America), pseudophakic bullous keratopathy/aphakic bullous keratop

76 es of 31 patients who had Fuchs dystrophy or pseudophakic bullus keratopathy (PBK) and underwent DSAE

77 The 50% glucose reached the vitreous in pseudophakic but not phakic individuals.

78 Of 661 pseudophakic cadaver eyes obtained, 13 had 3-piece hydro

79 rred and immediate surgical groups when only pseudophakic cases were analyzed.

80 In 25% of pseudophakic cases, posterior capsule opacification was

81 arithm of the minimal angle of resolution in pseudophakic children at last follow-up (P < .0001).

82 range, 0.00-1.18 logMAR) in both aphakic and pseudophakic children.

83 e centers for Fuchs' endothelial disease and pseudophakic corneal edema and for high-volume surgeons

84 Performing earlier DSEK for pseudophakic corneal edema appears to be associated with

85 keratoconus, Fuchs' endothelial disease, or pseudophakic corneal edema in a 7-year period from 1999

86 ptimal time to perform DSEK in patients with pseudophakic corneal edema.

87 Pseudophakic cystic macular edema, also known as Irvine-

88 the association between serum biomarkers and pseudophakic cystoid macular edema (PCME) in eyes withou

89 Pseudophakic cystoid macular edema (PCME) is a common ca

90 ed phacoemulsification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospe

91 At 28 days postsurgery, pseudophakic cystoid macular edema (PCME) was reported i

92 h topical nepafenac 0.3% in the treatment of pseudophakic cystoid macular edema (PCME).

93 Pseudophakic cystoid macular edema is an important cause

94 Pseudophakic cystoid macular edema is common after phaco

95 TA) versus laser; (2) a subgroup analysis of pseudophakic DME eyes shows equivalent visual results wi

96 IOL implantation, optical correction of the pseudophakic eye to a near point, and 70% occlusion of t

97 ely and predict the refractive change of the pseudophakic eye to maturity.

98 Only 2 of these patients had a pseudophakic eye.

99 relative intensity values between phakic and pseudophakic eyes (0.3522 vs 0.3577, P = .48) and betwee

100 Age-normal VA was achieved by 6 pseudophakic eyes (21%; 95% CI, 10%-38%) and 1 aphakic e

101 e, 20/32 to 20/230) in 186 of 364 unilateral pseudophakic eyes (51%).

102 nge, 20/25 to 20/50) in 209 of 386 bilateral pseudophakic eyes (54%), 20/200 (range, 20/50 to 20/618)

103 year period prevalence of glaucoma was 9% in pseudophakic eyes (95% CI, 1%-16%) and 9% in aphakic eye

104 tive incidence of surgery for VAO was 47% in pseudophakic eyes (95% CI, 31%-60%) and 13% in aphakic e

105 taract surgery within 3 years (group B), and pseudophakic eyes (group C).

106 ticipants [49%]) was 20/63 (20/35-20/159) in pseudophakic eyes (n = 29; mean [SD] age at surgery, 7.2

107 er DSEK or PK compared with otherwise normal pseudophakic eyes (P < 0.001) but did not differ between

108 for phakic eyes was 64.50% versus 53.93% for pseudophakic eyes (P < 0.001).

109 = 8,), and not with age of otherwise normal pseudophakic eyes (r = 0.32, P = 0.18, n = 29).

110 The 50% width was higher in pseudophakic eyes after DSEK or PK compared with otherwi

111 dth, small-angle domain) were measured in 40 pseudophakic eyes after keratoplasty (Descemet stripping

112 Aphakic and pseudophakic eyes and eyes with best corrected visual ac

113 t implantation through the ciliary sulcus in pseudophakic eyes appears relatively safe to the corneal

114 ive error per year and visual acuity for the pseudophakic eyes at last follow-up visit.

115 ant retinal tears were excluded, leaving 893 pseudophakic eyes eligible for outcome analysis.

116 t daily 70% occlusion, grating acuity in the pseudophakic eyes eventually matured to normal adult lev

117 ies study, in which 20 trabeculectomised and pseudophakic eyes from 15 patients, with otherwise well

118 Pseudophakic eyes had a threefold higher odds of OHT com

119 The majority of pseudophakic eyes had significant anisometropia at age 5

120 tamponade was achieved in phakic as well as pseudophakic eyes irrespective of AL of the eye.

121 Retinal image quality in pseudophakic eyes is limited by the wavefront aberration

122 Angle-closure in pseudophakic eyes is uncommon.

123 ant a tube into the posterior chamber of the pseudophakic eyes is uncomplicated and facilitates the i

124 h 5-year follow-up, while nearly half of the pseudophakic eyes needed surgery for VAO supporting the

125 Twenty two pseudophakic eyes of 22 consecutive patients were includ

126 Sixty-one otherwise healthy pseudophakic eyes of 38 subjects with FECD (without clin

127 Fifty-four pseudophakic eyes of 54 patients with corneal endothelia

128 y detectable edema) and 17 otherwise healthy pseudophakic eyes of 9 subjects with normal corneas.

129 Cologne DMEK database who underwent DMEK in pseudophakic eyes or DMEK in combination with cataract s

130 ls of ketorolac were significantly higher in pseudophakic eyes than in phakic eyes.

131 25G HS-PPV (348 eyes), and group B included pseudophakic eyes that underwent 25G HS-PPV alone (217 e

132 A total of 279 pseudophakic eyes that underwent lens extraction at a pr

133 t the optical correction of both aphakic and pseudophakic eyes to a near point (3-5 D).

134 used to adjust the optical correction of the pseudophakic eyes to a near point, and opaque lenses wer

135 "push-plus" technique should be used in all pseudophakic eyes to avoid over-minus prescriptions, esp

136 Other studies have shown a tendency for pseudophakic eyes to progress to the wet form of age-rel

137 on of the two treatment groups revealed that pseudophakic eyes treated with multifocal IOLs had signi

138 ariability in refractive change was found in pseudophakic eyes undergoing surgery at 1 to < 7 months

139 pril 2010 and August 2012 were reviewed; 292 pseudophakic eyes underwent DMEK (group 1) and 200 eyes

140 traocular lens implantation; 20 preoperative pseudophakic eyes underwent PPV and ILM peeling only.

141 rst-line methods; the second-line therapy in pseudophakic eyes was laser hyaloidotomy, followed by vi

142 en the mean axial lengths of the aphakic and pseudophakic eyes was not significant (P > 0.10).

143 Longitudinal axial elongation of the pseudophakic eyes was then compared to that of the fello

144 When only pseudophakic eyes were analyzed, mean (SD) PGE2 levels w

145 %) of aphakic eyes and 3% (95% CI, 2%-5%) of pseudophakic eyes were diagnosed as glaucoma suspect.

146 Aphakic and pseudophakic eyes were excluded as well as eyes with bes

147 Pseudophakic eyes were more likely to fail primary PnR.

148 Pseudophakic eyes were more likely to lose 15 or more le

149 Glaucoma and pseudophakic eyes were significantly associated with CMV

150 At 5 weeks of age, aphakic and pseudophakic eyes were significantly shorter than their

151 Phakic and pseudophakic eyes were treated with monthly intravitreal

152 r bag complex integrity to the vitrectomized pseudophakic eyes with intact zonular/capsular bags, the

153 ieved in 4 eyes with medical treatment, in 7 pseudophakic eyes with laser hyaloidotomy, in 4 eyes wit

154 utomated refraction yields myopic results in pseudophakic eyes with monofocal and presbyopia correcti

155 For the study population, 240 pseudophakic eyes with PCO and a capsulotomy indication

156 The depth and width of the ACA in pseudophakic eyes with PCO increased significantly after

157 Anterior chamber depth and angle width in pseudophakic eyes with posterior capsule opacification w

158 rs plana vitrectomy (PPV) for ERM removal in pseudophakic eyes with these IOLs.

159 For the reference population, 99 pseudophakic eyes without PCO were selected.

160 and 12 months after surgery 31 patients (39 pseudophakic eyes) underwent a complete ophthalmological

161 IQR, -3.13 D to -0.25 D) among 130 bilateral pseudophakic eyes, -10.75 D (IQR, -20.50 D to -4.50 D) a

162 2.4% for retinal detachment, and, excluding pseudophakic eyes, 64.6% underwent cataract surgery with

163 nge in 3 groups: (1) eyes with cataract, (2) pseudophakic eyes, and (3) eyes in which cataract surger

164 All 7 were in pseudophakic eyes, and 4 of the 5 below this limit were

165 c eyes, laser hyaloidotomy was beneficial in pseudophakic eyes, and vitrectomy and TSCPC were benefic

166 specially in higher-risk groups such as men, pseudophakic eyes, eyes with lattice/peripheral retinal

167 The vitrectomized pseudophakic eyes, in contrast to the nonvitrectomized p

168 Neither of the 2 factors evaluated for pseudophakic eyes, laterality and anterior vitrectomy, w

169 The increase was observed in both phakic and pseudophakic eyes, suggesting that cataract extraction c

170 ic eyes, in contrast to the nonvitrectomized pseudophakic eyes, were significantly associated with an

171 cular pressure and glaucoma, particularly in pseudophakic eyes, where the natural lens barrier is abs

172 ve inclusion criteria, as well as phakic and pseudophakic eyes.

173 compared with 25G HS-PPV alone performed in pseudophakic eyes.

174 ts with the CFH or ARMS2 risk genotypes, and pseudophakic eyes.

175 seen in mean change in VA for phakic versus pseudophakic eyes.

176 Fuchs' dystrophy and in 30 otherwise normal pseudophakic eyes.

177 ling and neural factors will limit vision in pseudophakic eyes.

178 owed worse visual acuity (VA) than phakic or pseudophakic eyes.

179 gful risk of OHT and glaucoma, especially in pseudophakic eyes.

180 phakic eyes whereas vitrectomy alone in 112 pseudophakic eyes.

181 mplant GDD tubes in the posterior chamber of pseudophakic eyes.

182 QR, -3.25 D to -0.69 D) among 112 unilateral pseudophakic eyes.

183 of Soemmering ring related angle-closure in pseudophakic eyes.

184 Fifty-nine eyes were phakic and 58 pseudophakic eyes.

185 sitive to improved reading accessibility for pseudophakic eyes.

186 in both BRVO and CRVO and in both phakic and pseudophakic eyes.

187 s postoperatively was similar for phakic and pseudophakic FECD eyes (39%; P = .852), but higher for B

188 nd BK eyes (P = .170), or between phakic and pseudophakic FECD eyes (P = .066) after correcting for p

189 226 cases (77%) had an uncomplicated pseudophakic fellow-eye history, with a routine surgery,

190 l series of eyes, both trabeculectomised and pseudophakic, following the laser application for the ma

191 MAR 0.21 vs 0.27; P >0.05) and phakic versus pseudophakic groups (logMAR 0.23 vs 0.28; P >0.05).

192 cular lens (IOL) designs in a series of 5416 pseudophakic human eyes obtained postmortem, accessioned

193 Age, axial length, lens status (phakic or pseudophakic), hypertensive status, ischemic heart disea

194 Most patients were pseudophakic in the fellow eye.

195 : 2.8-3.3]; HR 1.1 [95% CrI: 1.09-1.12]) and pseudophakic individuals (OR: 1.7 [95% CrI: 1.6-1.8]; HR

196 Pseudophakic individuals exhibit a 27% reduction in frac

197 Moderate-certainty evidence indicates that pseudophakic individuals have the lowest fracture risk c

198 ed with phakic subjects without cataract and pseudophakic individuals.

199 ithin the first 12 months of follow-up in 38 pseudophakic infants (life-table estimate, 66.7%) and 42

200 His pseudophakic left eye had a failed superonasal trabecule

201 Decentration and tilt of the crystalline and pseudophakic lenses were assessed before surgery and at

202 ne and peribulbar triamcinolone) in treating pseudophakic macular edema (PME).

203 Pseudophakic macular edema occurs commonly after phacoem

204 betic macular edema, retinal vein occlusion, pseudophakic macular edema, and uveitis.

205 A 75-year-old pseudophakic man with open-angle glaucoma and diabetic r

206 ient with keratoconus, as well as to correct pseudophakic myopia.

207 The most common indication for DMEK was pseudophakic or aphakic bullous keratopathy (PBK), follo

208 dothelial corneal dystrophy (94% of eyes) or pseudophakic or aphakic corneal edema (6% of eyes).

209 K for Fuchs dystrophy (1255 eyes [94.4%]) or pseudophakic or aphakic corneal edema (75 eyes [5.6%]).

210 sk condition, principally Fuchs dystrophy or pseudophakic or aphakic corneal edema (PACE).

211 k condition, principally Fuchs' dystrophy or pseudophakic or aphakic corneal edema, were enrolled by

212 RD repair were estimated for both phakic and pseudophakic or aphakic patients and then were compared.

213 12% less expensive than SB for RRD repair in pseudophakic or aphakic patients.

214 In patients who were pseudophakic or were scheduled for cataract extraction,

215 An 85-year-old male pseudophakic patient affected by pseudoexfoliative glauc

216 groups of 9 normal subjects (17 eyes) and 17 pseudophakic patients (17 eyes) implanted with monofocal

217 Twelve pseudophakic patients (23 eyes) with a Symfony lens (Joh

218 tiColor imaging that occurs predominantly in pseudophakic patients and may be mistaken for true chori

219 Pseudophakic patients had a higher OR for PVR developmen

220 Older pseudophakic patients have generally the same contrast s

221 especially elderly, non-Hispanic White, and pseudophakic patients in non-Northeast regions.

222 Rates of macular edema in pseudophakic patients increased with prolonged OMDI expo

223 PPV was preferred over SB in pseudophakic patients or those with media opacity and po

224 his single academic center study reviewed 74 pseudophakic patients who had a diagnosis of glaucoma an

225 By examining pseudophakic patients who had extended-depth-of-focus di

226 In bilaterally pseudophakic patients who received immediate or delayed

227 Twenty pseudophakic patients who underwent ultrasound biomicros

228 Nondiabetic pseudophakic patients with definite POAG were recruited;

229 SCPC) as an initial surgical intervention in pseudophakic patients with glaucoma.

230 ofile as an initial surgical intervention in pseudophakic patients with glaucoma.

231 MNI surgical system (Sight Sciences, Inc) in pseudophakic patients with mild to moderate open-angle g

232 to correct residual amounts of ametropia in pseudophakic patients with monofocal intraocular lenses;

233 Early postoperative pseudophakic patients with myopic shift and narrow angle

234 nd-alone procedures using the OMNI system in pseudophakic patients with open-angle glaucoma provides

235 Pseudophakic patients with RRD managed with PPV or PPV-S

236 ingle institution, 43 eyes of 43 consecutive pseudophakic patients with symptomatic posterior capsule

237 membrane endothelial keratoplasty (DMEK) in pseudophakic patients with the outcomes after DMEK combi

238 For pseudophakic patients, first-line treatment with triamci

239 In pseudophakic patients, the failure rate of the initial p

240 atment for retinal detachment, especially in pseudophakic patients.

241 fter cataract surgery was similar to that in pseudophakic patients.

242 occur commonly in younger, nonhyperopic, and pseudophakic patients.

243 eratectomy are safe and effective results in pseudophakic patients.

244 raction, benefitting a growing population of pseudophakic patients.

245 Phakic and pseudophakic piggyback intraocular lenses are also being

246 Astigmatism and pseudophakic presbyopia continue as the primary indicati

247 der than 70 years are more likely to develop pseudophakic PVD.

248 arman) = -0.27, p < 0.01), but more so among pseudophakic (r(Spearman) = -0.41, p < 0.01) than aphaki

249 For all eyes (both with and without PCR), pseudophakic RD occurred earlier in cases performed by a

250 Pseudophakic RD occurs earlier after cataract surgery co

251 Pseudophakic RD showed significant differences compared

252 progressed to RD surgery, the median time to pseudophakic RD surgery was 44 days for eyes with PCR, a

253 Pseudophakic RD surgery was performed on 131 eyes of 129

254 cataract exhibited several similarities with pseudophakic RD, including greater age, more frequent fo

255 Despite the more advanced features of pseudophakic RD, pseudophakia was a positive factor for

256 aract shared several features in common with pseudophakic RD.

257 Surgeon grade is a risk factor for pseudophakic RD.

258 ye has been successfully expanded to address pseudophakic refractive error in normal eyes and eyes th

259 rent literature further defines the risk for pseudophakic retinal detachment associated with younger

260 dentifying factors that increase the risk of pseudophakic retinal detachment can aid in management.

261 e of cataract surgeries performed each year, pseudophakic retinal detachment contributes significantl

262 ontinue to be associated with higher risk of pseudophakic retinal detachment.

263 This study evaluates outcomes of comparable pseudophakic rhegmatogenous retinal detachment (RRD) tre

264 attachment rate in the management of primary pseudophakic RRD due to IRBs.

265 In pseudophakic RRDs, SSAS was better in patients treated w

266 the loss of accommodation resulting from the pseudophakic state.

267 r studies, the significance of phakic versus pseudophakic status was not confirmed.

268 Pseudophakic study eyes demonstrated increased IOP when

269 Mean IOP for pseudophakic study eyes increased from 14.5+/-3.2 mmHg a

270 rence in the magnitude of change between the pseudophakic subgroups of the deferred and immediate sur

271 from preoperative BCVA to final BCVA in the pseudophakic subgroups was 0.22 (P = 0.0082) in the form

272 orse in those with known, treated OAG and in pseudophakic subjects.

273 refraction from medical records was used for pseudophakic subjects.

274 acts, with 1 less fracture event for every 8 pseudophakic subjects.

275 Contralateral RD was more frequent in pseudophakic than phakic RD eyes (P < .0001).

276 For pseudophakics, the ICER value for comparison triamcinolo

277 For pseudophakic uncomplicated retinal detachments, the surg

278 of 3-piece IOL models may reduce the risk of pseudophakic VAO in children younger than 2 years of age

279 ring treatment and 46% had cataracts or were pseudophakic, versus 18% with CMO and 59% with cataracts

280 aberration added by traditional IOLs to the pseudophakic visual axis.

281 rs, 62.5% female, 52% treatment naive, 35.4% pseudophakic) were assessed.

282 with microbial keratitis, who were older and pseudophakic, were prone to have more severe vitreous op

283 eyes with ghost maculopathy were found to be pseudophakic with a posterior chamber intraocular lens.

284 r 2013 in UK for treatment of eyes which are pseudophakic with DMO that is unresponsive to other avai

285 Univariate analysis was performed to compare pseudophakic with phakic RD, and phakic RD with and with

286 Eligible patients were pseudophakic, with mild/moderate open-angle glaucoma, 12

287 Eligible patients were pseudophakic, with mild/moderate open-angle glaucoma, 12

288 n phakic eyes was 94.9% compared to 93.1% in pseudophakic, with no statistically significant differen